Anti-Obesity Prescription Drugs Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Anti-Obesity Prescription Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-Obesity Prescription Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-Obesity Prescription Drugs Overall Market Size
2.1 Global Anti-Obesity Prescription Drugs Market Size: 2021 VS 2027
2.2 Global Anti-Obesity Prescription Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Anti-Obesity Prescription Drugs Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Anti-Obesity Prescription Drugs Players in Global Market
3.2 Top Global Anti-Obesity Prescription Drugs Companies Ranked by Revenue
3.3 Global Anti-Obesity Prescription Drugs Revenue by Companies
3.4 Global Anti-Obesity Prescription Drugs Sales by Companies
3.5 Global Anti-Obesity Prescription Drugs Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Anti-Obesity Prescription Drugs Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Anti-Obesity Prescription Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-Obesity Prescription Drugs Players in Global Market
3.8.1 List of Global Tier 1 Anti-Obesity Prescription Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti-Obesity Prescription Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-Obesity Prescription Drugs Market Size Markets, 2021 & 2027
4.1.2 Pediatric
4.1.3 Adult
4.2 By Type - Global Anti-Obesity Prescription Drugs Revenue & Forecasts
4.2.1 By Type - Global Anti-Obesity Prescription Drugs Revenue, 2016-2021
4.2.2 By Type - Global Anti-Obesity Prescription Drugs Revenue, 2022-2027
4.2.3 By Type - Global Anti-Obesity Prescription Drugs Revenue Market Share, 2016-2027
4.3 By Type - Global Anti-Obesity Prescription Drugs Sales & Forecasts
4.3.1 By Type - Global Anti-Obesity Prescription Drugs Sales, 2016-2021
4.3.2 By Type - Global Anti-Obesity Prescription Drugs Sales, 2022-2027
4.3.3 By Type - Global Anti-Obesity Prescription Drugs Sales Market Share, 2016-2027
4.4 By Type - Global Anti-Obesity Prescription Drugs Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti-Obesity Prescription Drugs Market Size, 2021 & 2027
5.1.2 Hospitals Pharmacies
5.1.3 Retail Pharmacies
5.1.4 E-commerce
5.2 By Application - Global Anti-Obesity Prescription Drugs Revenue & Forecasts
5.2.1 By Application - Global Anti-Obesity Prescription Drugs Revenue, 2016-2021
5.2.2 By Application - Global Anti-Obesity Prescription Drugs Revenue, 2022-2027
5.2.3 By Application - Global Anti-Obesity Prescription Drugs Revenue Market Share, 2016-2027
5.3 By Application - Global Anti-Obesity Prescription Drugs Sales & Forecasts
5.3.1 By Application - Global Anti-Obesity Prescription Drugs Sales, 2016-2021
5.3.2 By Application - Global Anti-Obesity Prescription Drugs Sales, 2022-2027
5.3.3 By Application - Global Anti-Obesity Prescription Drugs Sales Market Share, 2016-2027
5.4 By Application - Global Anti-Obesity Prescription Drugs Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Anti-Obesity Prescription Drugs Market Size, 2021 & 2027
6.2 By Region - Global Anti-Obesity Prescription Drugs Revenue & Forecasts
6.2.1 By Region - Global Anti-Obesity Prescription Drugs Revenue, 2016-2021
6.2.2 By Region - Global Anti-Obesity Prescription Drugs Revenue, 2022-2027
6.2.3 By Region - Global Anti-Obesity Prescription Drugs Revenue Market Share, 2016-2027
6.3 By Region - Global Anti-Obesity Prescription Drugs Sales & Forecasts
6.3.1 By Region - Global Anti-Obesity Prescription Drugs Sales, 2016-2021
6.3.2 By Region - Global Anti-Obesity Prescription Drugs Sales, 2022-2027
6.3.3 By Region - Global Anti-Obesity Prescription Drugs Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Anti-Obesity Prescription Drugs Revenue, 2016-2027
6.4.2 By Country - North America Anti-Obesity Prescription Drugs Sales, 2016-2027
6.4.3 US Anti-Obesity Prescription Drugs Market Size, 2016-2027
6.4.4 Canada Anti-Obesity Prescription Drugs Market Size, 2016-2027
6.4.5 Mexico Anti-Obesity Prescription Drugs Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Anti-Obesity Prescription Drugs Revenue, 2016-2027
6.5.2 By Country - Europe Anti-Obesity Prescription Drugs Sales, 2016-2027
6.5.3 Germany Anti-Obesity Prescription Drugs Market Size, 2016-2027
6.5.4 France Anti-Obesity Prescription Drugs Market Size, 2016-2027
6.5.5 U.K. Anti-Obesity Prescription Drugs Market Size, 2016-2027
6.5.6 Italy Anti-Obesity Prescription Drugs Market Size, 2016-2027
6.5.7 Russia Anti-Obesity Prescription Drugs Market Size, 2016-2027
6.5.8 Nordic Countries Anti-Obesity Prescription Drugs Market Size, 2016-2027
6.5.9 Benelux Anti-Obesity Prescription Drugs Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Anti-Obesity Prescription Drugs Revenue, 2016-2027
6.6.2 By Region - Asia Anti-Obesity Prescription Drugs Sales, 2016-2027
6.6.3 China Anti-Obesity Prescription Drugs Market Size, 2016-2027
6.6.4 Japan Anti-Obesity Prescription Drugs Market Size, 2016-2027
6.6.5 South Korea Anti-Obesity Prescription Drugs Market Size, 2016-2027
6.6.6 Southeast Asia Anti-Obesity Prescription Drugs Market Size, 2016-2027
6.6.7 India Anti-Obesity Prescription Drugs Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Anti-Obesity Prescription Drugs Revenue, 2016-2027
6.7.2 By Country - South America Anti-Obesity Prescription Drugs Sales, 2016-2027
6.7.3 Brazil Anti-Obesity Prescription Drugs Market Size, 2016-2027
6.7.4 Argentina Anti-Obesity Prescription Drugs Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Anti-Obesity Prescription Drugs Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Anti-Obesity Prescription Drugs Sales, 2016-2027
6.8.3 Turkey Anti-Obesity Prescription Drugs Market Size, 2016-2027
6.8.4 Israel Anti-Obesity Prescription Drugs Market Size, 2016-2027
6.8.5 Saudi Arabia Anti-Obesity Prescription Drugs Market Size, 2016-2027
6.8.6 UAE Anti-Obesity Prescription Drugs Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 F Hoffmann La Roche Ltd
7.1.1 F Hoffmann La Roche Ltd Corporate Summary
7.1.2 F Hoffmann La Roche Ltd Business Overview
7.1.3 F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Major Product Offerings
7.1.4 F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Sales and Revenue in Global (2016-2021)
7.1.5 F Hoffmann La Roche Ltd Key News
7.2 Orexigen Therapeutics
7.2.1 Orexigen Therapeutics Corporate Summary
7.2.2 Orexigen Therapeutics Business Overview
7.2.3 Orexigen Therapeutics Anti-Obesity Prescription Drugs Major Product Offerings
7.2.4 Orexigen Therapeutics Anti-Obesity Prescription Drugs Sales and Revenue in Global (2016-2021)
7.2.5 Orexigen Therapeutics Key News
7.3 Novo Nordisk A/s
7.3.1 Novo Nordisk A/s Corporate Summary
7.3.2 Novo Nordisk A/s Business Overview
7.3.3 Novo Nordisk A/s Anti-Obesity Prescription Drugs Major Product Offerings
7.3.4 Novo Nordisk A/s Anti-Obesity Prescription Drugs Sales and Revenue in Global (2016-2021)
7.3.5 Novo Nordisk A/s Key News
7.4 Arena Pharmaceuticals
7.4.1 Arena Pharmaceuticals Corporate Summary
7.4.2 Arena Pharmaceuticals Business Overview
7.4.3 Arena Pharmaceuticals Anti-Obesity Prescription Drugs Major Product Offerings
7.4.4 Arena Pharmaceuticals Anti-Obesity Prescription Drugs Sales and Revenue in Global (2016-2021)
7.4.5 Arena Pharmaceuticals Key News
7.5 Glaxosmithkline
7.5.1 Glaxosmithkline Corporate Summary
7.5.2 Glaxosmithkline Business Overview
7.5.3 Glaxosmithkline Anti-Obesity Prescription Drugs Major Product Offerings
7.5.4 Glaxosmithkline Anti-Obesity Prescription Drugs Sales and Revenue in Global (2016-2021)
7.5.5 Glaxosmithkline Key News
7.6 Vivus
7.6.1 Vivus Corporate Summary
7.6.2 Vivus Business Overview
7.6.3 Vivus Anti-Obesity Prescription Drugs Major Product Offerings
7.6.4 Vivus Anti-Obesity Prescription Drugs Sales and Revenue in Global (2016-2021)
7.6.5 Vivus Key News
7.7 Boehringer Ingelheim
7.7.1 Boehringer Ingelheim Corporate Summary
7.7.2 Boehringer Ingelheim Business Overview
7.7.3 Boehringer Ingelheim Anti-Obesity Prescription Drugs Major Product Offerings
7.4.4 Boehringer Ingelheim Anti-Obesity Prescription Drugs Sales and Revenue in Global (2016-2021)
7.7.5 Boehringer Ingelheim Key News
7.8 Alizyme
7.8.1 Alizyme Corporate Summary
7.8.2 Alizyme Business Overview
7.8.3 Alizyme Anti-Obesity Prescription Drugs Major Product Offerings
7.8.4 Alizyme Anti-Obesity Prescription Drugs Sales and Revenue in Global (2016-2021)
7.8.5 Alizyme Key News
8 Global Anti-Obesity Prescription Drugs Production Capacity, Analysis
8.1 Global Anti-Obesity Prescription Drugs Production Capacity, 2016-2027
8.2 Anti-Obesity Prescription Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-Obesity Prescription Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti-Obesity Prescription Drugs Supply Chain Analysis
10.1 Anti-Obesity Prescription Drugs Industry Value Chain
10.2 Anti-Obesity Prescription Drugs Upstream Market
10.3 Anti-Obesity Prescription Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti-Obesity Prescription Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer


List of Tables
Table 1. Key Players of Anti-Obesity Prescription Drugs in Global Market
Table 2. Top Anti-Obesity Prescription Drugs Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Anti-Obesity Prescription Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Anti-Obesity Prescription Drugs Revenue Share by Companies, 2016-2021
Table 5. Global Anti-Obesity Prescription Drugs Sales by Companies, (K Units), 2016-2021
Table 6. Global Anti-Obesity Prescription Drugs Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Anti-Obesity Prescription Drugs Price (2016-2021) & (US$/Unit)
Table 8. Global Manufacturers Anti-Obesity Prescription Drugs Product Type
Table 9. List of Global Tier 1 Anti-Obesity Prescription Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-Obesity Prescription Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Anti-Obesity Prescription Drugs Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Anti-Obesity Prescription Drugs Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Anti-Obesity Prescription Drugs Sales (K Units), 2016-2021
Table 15. By Type - Global Anti-Obesity Prescription Drugs Sales (K Units), 2022-2027
Table 16. By Application - Global Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Anti-Obesity Prescription Drugs Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Anti-Obesity Prescription Drugs Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Anti-Obesity Prescription Drugs Sales (K Units), 2016-2021
Table 20. By Application - Global Anti-Obesity Prescription Drugs Sales (K Units), 2022-2027
Table 21. By Region - Global Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Anti-Obesity Prescription Drugs Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Anti-Obesity Prescription Drugs Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Anti-Obesity Prescription Drugs Sales (K Units), 2016-2021
Table 25. By Region - Global Anti-Obesity Prescription Drugs Sales (K Units), 2022-2027
Table 26. By Country - North America Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Anti-Obesity Prescription Drugs Sales, (K Units), 2016-2021
Table 29. By Country - North America Anti-Obesity Prescription Drugs Sales, (K Units), 2022-2027
Table 30. By Country - Europe Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Anti-Obesity Prescription Drugs Sales, (K Units), 2016-2021
Table 33. By Country - Europe Anti-Obesity Prescription Drugs Sales, (K Units), 2022-2027
Table 34. By Region - Asia Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Anti-Obesity Prescription Drugs Sales, (K Units), 2016-2021
Table 37. By Region - Asia Anti-Obesity Prescription Drugs Sales, (K Units), 2022-2027
Table 38. By Country - South America Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Anti-Obesity Prescription Drugs Sales, (K Units), 2016-2021
Table 41. By Country - South America Anti-Obesity Prescription Drugs Sales, (K Units), 2022-2027
Table 42. By Country - Middle East & Africa Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Anti-Obesity Prescription Drugs Sales, (K Units), 2016-2021
Table 45. By Country - Middle East & Africa Anti-Obesity Prescription Drugs Sales, (K Units), 2022-2027
Table 46. F Hoffmann La Roche Ltd Corporate Summary
Table 47. F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Product Offerings
Table 48. F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 49. Orexigen Therapeutics Corporate Summary
Table 50. Orexigen Therapeutics Anti-Obesity Prescription Drugs Product Offerings
Table 51. Orexigen Therapeutics Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 52. Novo Nordisk A/s Corporate Summary
Table 53. Novo Nordisk A/s Anti-Obesity Prescription Drugs Product Offerings
Table 54. Novo Nordisk A/s Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 55. Arena Pharmaceuticals Corporate Summary
Table 56. Arena Pharmaceuticals Anti-Obesity Prescription Drugs Product Offerings
Table 57. Arena Pharmaceuticals Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 58. Glaxosmithkline Corporate Summary
Table 59. Glaxosmithkline Anti-Obesity Prescription Drugs Product Offerings
Table 60. Glaxosmithkline Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 61. Vivus Corporate Summary
Table 62. Vivus Anti-Obesity Prescription Drugs Product Offerings
Table 63. Vivus Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 64. Boehringer Ingelheim Corporate Summary
Table 65. Boehringer Ingelheim Anti-Obesity Prescription Drugs Product Offerings
Table 66. Boehringer Ingelheim Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 67. Alizyme Corporate Summary
Table 68. Alizyme Anti-Obesity Prescription Drugs Product Offerings
Table 69. Alizyme Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 70. Anti-Obesity Prescription Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2019-2021 (K Units)
Table 71. Global Anti-Obesity Prescription Drugs Capacity Market Share of Key Manufacturers, 2019-2021
Table 72. Global Anti-Obesity Prescription Drugs Production by Region, 2016-2021 (K Units)
Table 73. Global Anti-Obesity Prescription Drugs Production by Region, 2022-2027 (K Units)
Table 74. Anti-Obesity Prescription Drugs Market Opportunities & Trends in Global Market
Table 75. Anti-Obesity Prescription Drugs Market Drivers in Global Market
Table 76. Anti-Obesity Prescription Drugs Market Restraints in Global Market
Table 77. Anti-Obesity Prescription Drugs Raw Materials
Table 78. Anti-Obesity Prescription Drugs Raw Materials Suppliers in Global Market
Table 79. Typical Anti-Obesity Prescription Drugs Downstream
Table 80. Anti-Obesity Prescription Drugs Downstream Clients in Global Market
Table 81. Anti-Obesity Prescription Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Anti-Obesity Prescription Drugs Segment by Type
Figure 2. Anti-Obesity Prescription Drugs Segment by Application
Figure 3. Global Anti-Obesity Prescription Drugs Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Anti-Obesity Prescription Drugs Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Anti-Obesity Prescription Drugs Revenue, 2016-2027 (US$, Mn)
Figure 7. Anti-Obesity Prescription Drugs Sales in Global Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Anti-Obesity Prescription Drugs Revenue in 2020
Figure 9. By Type - Global Anti-Obesity Prescription Drugs Sales Market Share, 2016-2027
Figure 10. By Type - Global Anti-Obesity Prescription Drugs Revenue Market Share, 2016-2027
Figure 11. By Type - Global Anti-Obesity Prescription Drugs Price (US$/Unit), 2016-2027
Figure 12. By Application - Global Anti-Obesity Prescription Drugs Sales Market Share, 2016-2027
Figure 13. By Application - Global Anti-Obesity Prescription Drugs Revenue Market Share, 2016-2027
Figure 14. By Application - Global Anti-Obesity Prescription Drugs Price (US$/Unit), 2016-2027
Figure 15. By Region - Global Anti-Obesity Prescription Drugs Sales Market Share, 2016-2027
Figure 16. By Region - Global Anti-Obesity Prescription Drugs Revenue Market Share, 2016-2027
Figure 17. By Country - North America Anti-Obesity Prescription Drugs Revenue Market Share, 2016-2027
Figure 18. By Country - North America Anti-Obesity Prescription Drugs Sales Market Share, 2016-2027
Figure 19. US Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Anti-Obesity Prescription Drugs Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Anti-Obesity Prescription Drugs Sales Market Share, 2016-2027
Figure 24. Germany Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2016-2027
Figure 25. France Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Anti-Obesity Prescription Drugs Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Anti-Obesity Prescription Drugs Sales Market Share, 2016-2027
Figure 33. China Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2016-2027
Figure 37. India Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Anti-Obesity Prescription Drugs Revenue Market Share, 2016-2027
Figure 39. By Country - South America Anti-Obesity Prescription Drugs Sales Market Share, 2016-2027
Figure 40. Brazil Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Anti-Obesity Prescription Drugs Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Anti-Obesity Prescription Drugs Sales Market Share, 2016-2027
Figure 44. Turkey Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2016-2027
Figure 48. Global Anti-Obesity Prescription Drugs Production Capacity (K Units), 2016-2027
Figure 49. The Percentage of Production Anti-Obesity Prescription Drugs by Region, 2020 VS 2027
Figure 50. Anti-Obesity Prescription Drugs Industry Value Chain
Figure 51. Marketing Channels

F Hoffmann La Roche Ltd
-rexigen Therapeutics
Novo Nordisk A/s
Arena Pharmaceuticals
Glaxosmithkline
Vivus
Boehringer Ingelheim
Alizyme